Lunit and Summit Therapeutics Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development
recent articles
Some time has passed since the learning and social marathon that is USCAP has concluded and more time will pass before I can do a full review of the commercial activities from the exhibit floor in Seattle. That being said, one of the companies...
Don’t miss out on the biggest cancer research event of the year We look forward to seeing you at the 2016 American Association of Cancer Research Annual Meeting, where we will be showcasing our extensive technology platforms for precision...
Dr. David Novis, a pathologist and President of Novis Consulting, LLC based out of New Hampshire wrote an interesting Letter to the Editor recently in the Archives of Pathology and Laboratory Medicine. In it, he looks at the role of quality...
Mikroscan recently announced news of the appointment of Dr. Martin Stuart as President. This is a name that should be familiar to many having most recently been with Definiens and Aperio, prior to their acquisition by Leica Biosystems,...
News today courtesy of Philips announcing MGH as a primary site for a clinical validation trial based here in the United States for reproducibility of whole slide imaging (WSI) to glass slides. The PI on the study, Dr. Joe Lennerz has been...
Enhancing the patient experience through a patient-centered approach to care is a growing priority for healthcare organizations. The primary objective of patient-centered care is to ensure a continuing relationship between the patient and his...
